MedPath

A study to assess the action of homeopathic medicines in hypertensio

Phase 3
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2023/07/055348
Lead Sponsor
Dr M P K Homoeopathic Medical College Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients suffering from essential hypertension of stage I & II as per JNC-VII criteria, not taking any antihypertensive treatment.

(Stage I: SBP 140-159 mm Hg, DBP 90-99 mm Hg)

(Stage II: SBP160-179 mmHg, DBP 100-109 mmHg)

2. Patients giving written informed consent.

3. Cases with no evidence of secondary causes from clinical history, examination and routine investigations.

Exclusion Criteria

1. Cases having risk of hypertensive emergencies

(SBP equal or more than 180 mm Hg & DBP equal or more than 120 mm Hg)

2. Patient taking any antihypertensive medicine

3. Immunocompromised patients

4. Diagnosed cases of HTN with developmental defects or congenital abnormalities.

4. Pregnant patients or on breast feeding and/ or with likelihood of pregnancy.

5. Patients with history of drug and/or alcohol abuse.

6. Patients not giving consent and maintaining follow up.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
At the end of study we expect that individualized homoeopathic medicines selected with the help of Complete Repertory will decrease Blood pressureTimepoint: 9 months
Secondary Outcome Measures
NameTimeMethod
Individualized homoeopathic medicines will help improve quality of life of patient which will be measured using MINICHAL questionnaire.Timepoint: 9 months
© Copyright 2025. All Rights Reserved by MedPath